Literature DB >> 27814937

Skeletal muscle depletion correlates with disease activity in ulcerative colitis and is reversed after colectomy.

Tenghui Zhang1, Chao Ding2, Tingbin Xie3, Jianbo Yang4, Xujie Dai5, Tengfei Lv6, Yi Li7, Lili Gu8, Yao Wei9, Jianfeng Gong10, Weiming Zhu11, Ning Li12, Jieshou Li13.   

Abstract

BACKGROUND & AIMS: The body composition of patients with ulcerative colitis (UC) remains unclear. This study evaluated body composition in adult patients with UC and the associations of body composition with disease activity and surgical intervention.
METHODS: This study included 99 patients with UC, 105 with Crohn's disease (CD) and 60 controls. Skeletal muscle area (SMA), visceral fat area (VFA) and subcutaneous fat area (SFA) of the third lumbar vertebrae were evaluated by abdominal computed tomography. The effects of medical therapy and surgery on body composition in UC patients were determined.
RESULTS: Sarcopenia was more frequent in UC patients (27.3%) than in controls (8.3%), but less frequent than in CD patients (59.0%). The prevalence of sarcopenia was significantly higher (33.8% vs. 4.5%, p < 0.001), and SMA (144.26 vs. 182.32 cm2, p < 0.001), skeletal muscle index (SMI) (52.22 vs. 65.52 cm2/m2, p < 0.001) significantly lower, in UC patients with high (≥6) than low (<6) Mayo score, but SFA and VFA were similar. The prevalence of sarcopenia and alterations in body composition were reversed, along with UC disease activity, following medical treatment or surgery. SMA and SMI correlated significantly with disease activity in UC patients. Multivariate analysis showed that sarcopenia (odds ratio, 8.49; 95% confidence interval, 1.80-40.10; p = 0.007) was a negative predictor of high Mayo score in UC patients. Sarcopenic patients with UC had high probability of need for colectomy in Kaplan-Meier survival curves.
CONCLUSIONS: Sarcopenia is associated with high disease activity and poor clinical outcome in UC patients. Medical treatment and colectomy have positive effects on sarcopenia and skeletal muscle depletion.
Copyright © 2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Body composition; Disease activity; Inflammatory bowel disease; Sarcopenia; Skeletal muscle mass; Ulcerative colitis

Mesh:

Substances:

Year:  2016        PMID: 27814937     DOI: 10.1016/j.clnu.2016.10.004

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  15 in total

1.  Evaluation of Nutritional Characteristics Reveals Similar Prevalence of Malnutrition in Patients with Ulcerative Colitis and Crohn's Disease.

Authors:  Arshdeep Singh; Vandana Midha; Ramit Mahajan; Shruti Verma; Chandan Kakkar; Jasmine Grover; Dharmatma Singh; Ramandeep Kaur; Abhishek Masih; Namita Bansal; Catherine Wall; Ajit Sood
Journal:  Dig Dis Sci       Date:  2022-09-05       Impact factor: 3.487

2.  Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients.

Authors:  Kelly C Cushing; Hamed Kordbacheh; Michael S Gee; Avinash Kambadakone; Ashwin N Ananthakrishnan
Journal:  J Crohns Colitis       Date:  2018-08-29       Impact factor: 9.071

Review 3.  Getting to grips with sarcopenia: recent advances and practical management for the gastroenterologist.

Authors:  Thomas William Hollingworth; Siddhartha M Oke; Harnish Patel; Trevor R Smith
Journal:  Frontline Gastroenterol       Date:  2020-01-20

4.  Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel Disease.

Authors:  Nik Sheng Ding; Daniel Tassone; Ibrahim Al Bakir; Kyle Wu; Alexander J Thompson; William R Connell; George Malietzis; Phillip Lung; Siddharth Singh; Chang-Ho Ryan Choi; Simon Gabe; John T Jenkins; Ailsa Hart
Journal:  J Crohns Colitis       Date:  2022-09-08       Impact factor: 10.020

5.  Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients.

Authors:  Weijie Gu; Junlong Wu; Xiaohang Liu; Hailiang Zhang; Guohai Shi; Yao Zhu; Dingwei Ye
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

6.  Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease.

Authors:  Shigeki Bamba; Masaya Sasaki; Azusa Takaoka; Kenichiro Takahashi; Hirotsugu Imaeda; Atsushi Nishida; Osamu Inatomi; Mitsushige Sugimoto; Akira Andoh
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

7.  The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease.

Authors:  Stephen O'Brien; Richard G Kavanagh; Brian W Carey; Michael M Maher; Owen J O'Connor; Emmet J Andrews
Journal:  Eur Radiol Exp       Date:  2018-11-21

8.  Systematic review of nutrition screening and assessment in inflammatory bowel disease.

Authors:  Suqing Li; Michael Ney; Tannaz Eslamparast; Ben Vandermeer; Kathleen P Ismond; Karen Kroeker; Brendan Halloran; Maitreyi Raman; Puneeta Tandon
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

Review 9.  Sarcopenia and Vitamin D Deficiency in Patients with Crohn's Disease: Pathological Conditions That Should Be Linked Together.

Authors:  Francesco Palmese; Rossella Del Toro; Giulia Di Marzio; Pierluigi Cataleta; Maria Giulia Sama; Marco Domenicali
Journal:  Nutrients       Date:  2021-04-20       Impact factor: 5.717

Review 10.  Sarcopenia in Autoimmune and Rheumatic Diseases: A Comprehensive Review.

Authors:  Hyo Jin An; Kalthoum Tizaoui; Salvatore Terrazzino; Sarah Cargnin; Keum Hwa Lee; Seoung Wan Nam; Jae Seok Kim; Jae Won Yang; Jun Young Lee; Lee Smith; Ai Koyanagi; Louis Jacob; Han Li; Jae Il Shin; Andreas Kronbichler
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.